Optiver Holding
PRCT icon

Optiver Holding’s Procept Biorobotics PRCT Stock Holding History

Optiver Holding’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25K Sell
188
-95
-34% -$2.38K ﹤0.01% 2043
2026
Q1 		$7.08K Buy
283
+122
+76% +$3.44K ﹤0.01% 1313
2025
Q4 		$5.07K Sell
161
-136
-46% -$4.51K ﹤0.01% 1366
2025
Q3 		$10.6K Sell
297
-26
-8% -$1.19K ﹤0.01% 1263
2025
Q2 		$18.6K Buy
323
+120
+59% +$6.79K ﹤0.01% 857
2025
Q1 		$11.8K Buy
+203
New +$13.9K ﹤0.01% 841

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Optiver Holding's PRCT Position: Q2 2026 in Review

Optiver Holding reduced its Procept Biorobotics (PRCT) stake by 34% in Q2 2026, selling an estimated $2.38K and leaving 188 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.

Optiver Holding first reported a position in PRCT in Q1 2025 and has held it in 6 quarters since. The position peaked at $18.6K in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Optiver Holding held 188 shares of Procept Biorobotics worth $4.25K as of Q2 2026.
  • Optiver Holding sold 95 Procept Biorobotics shares in Q2 2026, an estimated $2.38K.
  • Procept Biorobotics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2043 holding.
  • Optiver Holding first reported a position in Procept Biorobotics in Q1 2025 and has held it in 6 quarters since.
  • Optiver Holding's Procept Biorobotics position peaked at $18.6K in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.